Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

ECTRIMS 2013 Day 3
iConquerMS™ Advances Patient-Driven Multiple Sclerosis Research
CMSC ACTRIMS Cooperative Annual Meeting
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
American Academy of Neurology Fall Conference 2014
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
The Oxford English Corpus: Facts about the language, The Story of Dictionaries
Combination of IFN beta-1a (Avonex) and mycophenolate mofetil (Cellcept) in multiple sclerosis.
Episode 43 with Dr. May Han on following patients through the course of their disease
Episode 63 with Dr. Helen Tremlett on studying sun exposure in MS
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.
USPTO list of patent term extensions
Episode 65 with Dr. Gisela Kobelt on the economics of long-term brain health in MS
ACTRIMS-ECTRIMS 2014 -- Day 3, morning
The Role of the Gut Microbiome on Multiple Sclerosis Risk and Progression
Episode 50 with Dr. David Tabby on balance vests for MS
Episode 47 with Dr. Hans Lassmann on oxidative stress in MS
Untangling TNF Trouble
MS Research Roundup: January 17, 2014
ACTRIMS-ECTRIMS 2014 -- Day 1, morning
Brain MRI results of DECIDE: a randomized, double-blind trial of DAC HYP vs. IFNβ-1a in RRMS patients
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.

Pages

« first
‹ previous
…
42
43
44
45
46
47
48
49
50
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By